Inhibition of NF-kappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol).
about
Promising new treatments for psoriasisSynergy of combined doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse modelsEffect of Pycnogenol® on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial.Single and multiple dose pharmacokinetics of maritime pine bark extract (pycnogenol) after oral administration to healthy volunteersDistribution of Constituents and Metabolites of Maritime Pine Bark Extract (Pycnogenol®) into Serum, Blood Cells, and Synovial Fluid of Patients with Severe Osteoarthritis: A Randomized Controlled Trial.Substance P in polymicrobial sepsis: molecular fingerprint of lung injury in preprotachykinin-A-/- mice.Natural anti-inflammatory agents for pain reliefFacilitated uptake of a bioactive metabolite of maritime pine bark extract (pycnogenol) into human erythrocytesHerbal supplement extends life span under some environmental conditions and boosts stress resistancePharmaceutical and nutraceutical effects of Pinus pinaster bark extractPycnogenol(®) treatment inhibits bone mineral density loss and trabecular deterioration in ovariectomized rats.Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.Combining oral contraceptives with a natural nuclear factor-kappa B inhibitor for the treatment of endometriosis-related pain.The potential for dietary factors to prevent or treat osteoarthritis.Hormones, herbal preparations and nutriceuticals for a better life after the menopause: part II.Inhibitory effects of French pine bark extract, Pycnogenol®, on alveolar bone resorption and on the osteoclast differentiation.Review on Sustained Relief of Osteoarthritis Symptoms with a Proprietary Extract from Pine Bark, Pycnogenol.Divergent and synergistic regulation of matrix metalloprotease production by cytokines in combination with C-C chemokines.Improvements of venous tone with pycnogenol in chronic venous insufficiency: an ex vivo study on venous segments.5-(3',4'-Dihydroxyphenyl-γ-valerolactone), a Major Microbial Metabolite of Proanthocyanidin, Attenuates THP-1 Monocyte-Endothelial Adhesion.Kidney flow and function in hypertension: protective effects of pycnogenol in hypertensive participants--a controlled study.Protective effects of pycnogenol against ischemia reperfusion-induced oxidative renal injury in rats.Effect of natural polyphenols (Pycnogenol) on oxidative stress markers in children suffering from Crohn's disease--a pilot study.Improvement in circulation and in cardiovascular risk factors with a proprietary isotonic bioflavonoid formula OPC-3.Cellular pharmacodynamic effects of Pycnogenol® in patients with severe osteoarthritis: a randomized controlled pilot study.The andrologist's contribution to a better life for ageing men: part 2.APOE genotype and neuropsychological outcome in mild-to-moderate traumatic brain injury: a pilot study.
P2860
Q24598008-C4A08B4E-9B67-4885-9758-5F0AFA3994DDQ24631610-A9FCE2D3-A8CB-466E-A415-1345B535B37BQ30843197-A2442DBE-ACCB-4BAB-95EF-F0ACE753BD6BQ33252739-E22E5ACA-CFDD-4BFC-8D58-24B97F0D75E0Q33749234-2CCC88BA-5E8B-4EC6-A4DB-B8FB8A11F255Q33830638-F62EF30C-D2FA-41EF-976C-AA5218E9BA8CQ34444693-EFC09B51-D7D8-443E-93B2-7204F99AA911Q34707090-4B3DA2FE-1A3F-4563-A622-4E06390A110FQ35448688-6431A5C2-F605-456B-86B0-47829F49DDE1Q35464201-2D076FE6-8B9A-4163-8FAF-01D27F23E4D6Q36046329-BC72AC9F-DDB1-4918-997A-9E42783B5717Q37380847-81C7F4DA-78B2-4110-AFB1-313E57A16E3BQ37414933-6282FADD-04E0-4B08-AF36-879CDFD1624CQ38191354-579E9816-B4E9-4FE5-B8CE-8D56CE7F1C78Q38350780-30DFA91C-2DC7-40AF-8466-13FB6CD589F3Q38945952-75DE82D4-3A2C-4C99-B37D-E5DFA38D0F69Q39150930-20DA90E5-0EB1-42B3-91C1-6D4432FDC625Q39644885-D7F48E6E-4330-430E-B8A9-5E95A857F516Q40177442-020FC097-6774-4705-9525-FE6E194C7BBBQ41181413-5B0DDF9C-F753-4A62-B6D0-48EB8AF6A6C4Q43185290-42C71771-F32C-45BE-96BA-BECE2FE0202DQ43265106-70AE9DB3-92C7-4909-A225-9E199F5D9A98Q43948099-47DAD30B-4090-4AC1-840A-A6E5C465B02BQ46483130-B4C1867A-EA16-4E92-BF41-FBC69725F535Q47158317-3F5B55B8-D1DA-4D4B-8875-C92AB65EC09AQ49170674-38AA29A1-610B-42D5-87FF-B3353EA21A71Q51010658-8B75D5C6-FD10-4508-AEB8-72A8B6B0B975
P2860
Inhibition of NF-kappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol).
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Inhibition of NF-kappaB activa ...... ine bark extract (Pycnogenol).
@ast
Inhibition of NF-kappaB activa ...... ine bark extract (Pycnogenol).
@en
Inhibition of NF-kappaB activa ...... of maritime pine bark extract
@nl
type
label
Inhibition of NF-kappaB activa ...... ine bark extract (Pycnogenol).
@ast
Inhibition of NF-kappaB activa ...... ine bark extract (Pycnogenol).
@en
Inhibition of NF-kappaB activa ...... of maritime pine bark extract
@nl
prefLabel
Inhibition of NF-kappaB activa ...... ine bark extract (Pycnogenol).
@ast
Inhibition of NF-kappaB activa ...... ine bark extract (Pycnogenol).
@en
Inhibition of NF-kappaB activa ...... of maritime pine bark extract
@nl
P2093
P2860
P356
P1476
Inhibition of NF-kappaB activa ...... ine bark extract (Pycnogenol).
@en
P2093
Anna Liptáková
Jana Muchová
Katarína Sumegová
Petra Högger
Tanja Grimm
Zdenka Duracková
Zuzana Chovanová
P2860
P2888
P356
10.1186/1476-9255-3-1
P577
2006-01-27T00:00:00Z
P5875
P6179
1047950653